SCHEMBL6180199

SCHEMBL6180199

CCOC(=O)c1ccc(NC(=O)NC2CN(C(=O)c3ccccc3)c3ccc(C)cc3N(CC(=O)c3ccccc3C)C2=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 5/20 0.43
TSHR P16473 2/20 0.43
CYP3A4 P08684 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
GAA P10253 2/20 0.42
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CCKBR P32239 3/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
CYP2C19 P33261 1/20 0.39
THRB P10828 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177496 0.94 CCKBR (0.48) TP53LMNAMAPTTSHRCYP3A4
SCHEMBL6176177 0.92 CYP3A4 (0.48) MAPTTSHRCYP3A4CCKBR
SCHEMBL6177002 0.87 CCKBR (0.47) TP53LMNAMAPTTSHRCYP3A4
SCHEMBL6179728 0.87 CCKBR (0.53) MAPTTSHRCYP3A4CCKBR
SCHEMBL6179079 0.86 CCKBR (0.49) MAPTTSHRCYP3A4KMT2ARAB9A
SCHEMBL6176935 0.85 CCKBR (0.46) TP53LMNAMAPTTSHRCYP3A4
SCHEMBL6181535 0.85 MAPK1 (0.44) TP53LMNAMAPTTSHRCYP3A4
SCHEMBL6176442 0.85 RAB9A (0.44) TP53LMNAMAPTTSHRCYP3A4
SCHEMBL6197175 0.85 CYP3A4 (0.44) TP53LMNAMAPTTSHRCYP3A4
SCHEMBL7950790 0.85 CCKBR (0.46) TP53LMNAMAPTTSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed